These findings collectively suggest that OTUD4 in Paneth cells promotes experimental colitis and S.t. infections in a manner of MyD88-dependent regulation of AMPs production (Fig. S7), indicating OTUD4 as a potential target for the treatment of IBD and bacterial infection. Here, OTUD4 is linked to bacterial infectious disease.